Cytek Biosciences to Participate in Upcoming Investor Conferences

About this update from Cytek Biosciences, Inc.

[{"type":"image","alt":"Cytek Biosciences, Inc.","displaySize":"","headline":null,"caption":"Cytek Biosciences, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":94,"url":"https://media.zenfs.com/en/globenewswire.com/bc3b354d3f50b53d40b4edfe89e7fd8f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3p0SVRz3IvMSXP918Y7IYw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/bc3b354d3f50b53d40b4edfe89e7fd8f","width":300,"height":94}},"lazy":false},{"type":"text","content":"FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences.","length":222,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"UBS Global Healthcare Conference in Palm Beach, FLParticipating in investor 1x1 meetings on Tuesday, November 11, 2025","length":119,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":119,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Stephens NASH25 Investment Conference in Nashville, TNFireside chat on November 19, 2025, at 9:00 a.m. Pacific Time /12:00 p.m. Eastern Time","length":141,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":141,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Piper Sandler 37th Annual Healthcare Conference in New York, NYFireside chat on December 3, 2025, at 6:00 a.m. Pacific Time / 9:00 a.m. Eastern Time","length":149,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":149,"olType":false},{"type":"text","content":"Interested parties may access live and archived webcasts of the presentations for the Stephens and Piper Sandler events referenced above on the “Investors” section of the company website at: investors.cytekbio.com.","length":214,"tagName":"p"},{"type":"text","content":"About Cytek Biosciences, Inc.Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP®) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal ...

More updates from Cytek Biosciences, Inc.